- cafead Feb 27, 2025 at 10:22: AM
via Indivior, which focuses on treatments for opioid use disorder (OUD), said that Crossley had had a "distinguished tenure" as CEO since taking the role in June 2020, but will be stepping down after a handover period and will also no longer hold a position on its board.
article source
article source